Fecha de publicación: 27/10/2016 Fuente: WIPO "miel" Anti-cancer compositions and methods are described herein. In particular, compositions including one or more of leelamine, a leelamine derivative, abietylamine, an abietylamine derivative, and an abietic acid derivative are described. Methods for treatment of pathological conditions particularly cancer, in a subject using one or more of leelamine, a leelamine derivative, abietylamine, an abietylamine derivative, and an abietic acid derivative are described, herein.
3200 0 Body weight
S.C. Cell i.p. drug Days
injection injection
Figure 8
3200 30 DMSO (M)
0 2
S.C. cell +~D i.p. drug ays
injection injection
Figure 9